Archive for July, 2009

Drug Safety Update July 2009: Vol 2 (12)

admin July 7th, 2009

The MHRA have published Drug Safety Update July 2009: Vol 2 (12):

  • Clopidogrel and proton pump inhibitors: interaction
  • Abacavir: risk of myocardial infarction – update from epidemiological studies
  • Use of long-acting ?-agonists in chronic obstructive pulmonary disease
  • Mycophenolate mofetil: pure red cell aplasia
  • Hydroxycut range of food supplements: risk of liver damage
  • Priadel Liquid: potential for dosing errors
  • Clarification: ACE inhibitors and angiotensin II receptor antagonists – use during breastfeeding
  • Patient Information Leaflet of the month: sulfasalazine
  • Consultation: proposals to strengthen and rationalise EU pharmacovigilance

Swine Flu ADR Portal

admin July 6th, 2009

The MHRA have launched a dedicated adverse drug reaction reporting site for antiviral medication:

With the increased usage of antiviral medicines (tamiflu and relenza) for the treatment of swine flu the MHRA has put place measures to monitor the safety of these important medicines. Suspected side effects to antivirals, and when available H1N1 swine flu vaccines, should be reported via a dedicated internet-based reporting system, the ‘Swine Flu ADR Portal’. The MHRA has developed this Portal to sit alongside the Yellow Card Scheme and act as the main channel through which healthcare professionals and patients/carers can report suspected side effects.

http://swineflu.mhra.gov.uk